Wild‐type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|22|3|1792-1804

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.22, Iss.3, 2018-03, pp. : 1792-1804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metformin protects against intestinal barrier dysfunction via AMPKα1‐dependent inhibition of JNK signalling activation

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 1, 2018-01 ,pp. : 546-557

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nicorandil regulates the macrophage skewing and ameliorates myofibroblasts by inhibition of RhoA/Rho‐kinase signalling in infarcted rats

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 2, 2018-02 ,pp. : 1056-1069

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ectodysplasin A regulates epithelial barrier function through sonic hedgehog signalling pathway

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 1, 2018-01 ,pp. : 230-240

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sphingosine‐1‐phosphate (S1P) enhances glomerular endothelial cells activation mediated by anti‐myeloperoxidase antibody‐positive IgG

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1769-1777

John Wiley & Sons Inc

Access to resources Recommend Favorite

rIL‐10 enhances IL‐10 signalling proteins in foetal alveolar type II cells exposed to hyperoxia

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 7, 2015-07 ,pp. : 1538-1547

John Wiley & Sons Inc

Access to resources Recommend Favorite